Affimed(AFMD)

产业链观察05-29 20:16

#药闻简讯# $Affimed(AFMD)$ AFM24联合阿替利珠单抗联合治疗EGFR野生型非小细胞肺癌获得快速通道认定查看全文

产业链观察05-24 18:05

#药闻简讯# $Affimed(AFMD)$ AFM 24联合atezolizumab治疗EGFR野生型（EGFR-WT）非小细胞肺癌（NSCLC）患者的II期研究的初步结果。#ASCO2024#
背景： 免疫疗法组合可能是克服对现有疗法的耐药性的有希望的策略。AFM24是一类第一个双特异性四价先天性细胞增殖剂，结合先天性效应细胞（NK细胞和...查看全文

财报披露「修正」

Affimed(AFMD)06-07 05:15

$Affimed(AFMD)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-156194  Act: 34  Size: 77 KB 网页链接查看全文

财报披露

Affimed(AFMD)05-28 18:55

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-147572  Act: 34  Size: 179 KB 网页链接查看全文

财报披露

Affimed(AFMD)06-12 20:05

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-159605  Act: 34  Size: 429 KB 网页链接查看全文

财报披露

Affimed(AFMD)06-27 04:55

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-169160  Act: 34  Size: 38 KB 网页链接查看全文

财报披露

Affimed(AFMD)06-03 18:15

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-152290  Act: 34  Size: 41 KB 网页链接查看全文

财报披露

Affimed(AFMD)05-24 05:25

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-146116  Act: 34  Size: 37 KB 网页链接查看全文

Takeabreak2021-04-09 23:24

$阿米瑞斯(AMRS)$ today announced the pricing of an underwritten public offering of an aggregate of 19,047,619 shares of its common stock at a public offering price of $15.75 per share, which consists of a secondary offering of 11,390,797 shares to be sold, in the aggregate, b...查看全文

Takeabreak2021-04-09 23:13

$Affimed(AFMD)$ 前几天8.2没出掉，今天竟然30%........查看全文

牛唐2021-04-09 20:23

$Affimed(AFMD)$ 两个月一倍的收益。$拼多多(PDD)$ $蔚来(NIO)$查看全文

Replix锐璞美股2021-04-09 19:31

$Affimed(AFMD)$ 数据不错，盘前涨了一些。
Affimed Announces Presentation at AACR Hi ghlighting Initial Data from Phase 1 St udy of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13
All four patients experienced significant disease red...查看全文

Mu_continent2021-04-09 19:27

$Affimed(AFMD)$这公司真的不错，关注度太低了。查看全文

Pharmachoi2021-04-09 18:47

$Affimed(AFMD)$ go🚀查看全文

Pharmachoi2021-04-09 18:31

$Affimed(AFMD)$ 4名患者2cr，2pr。查看全文

牛唐2021-04-01 12:03

医药板块观察（2021.03.31）
1、$Affimed Therapeutics(AFMD)$ 核心仓位已有50%的收益，后续如何操作？
2、又一眼科领域白马股跌出机会，是否值得入手？同时有一只烟蒂股和短期交易股出现机会，如何配置？
3、$Bioxcel Therapeutics Inc.(BTAI)$ 数据不好，是否有抄底机会？
$小米...查看全文

Takeabreak2021-03-24 22:08

$Affimed(AFMD)$ Wells Fargo analyst Nick Abbott raised the firm's price target on Affimed N.V. to $15 from $10 following a call with management and based on inclusion of ROCK-platform derived AFM24 in his model in the context of continued Phase 1 dose escalation and furth...查看全文

Replix锐璞美股2021-03-22 09:55

$F-star Therapeutics(FSTX)$ 这家公司和2018年的$Affimed(AFMD)$ 比较像，默默无闻，专注双抗。FSTX在双抗领域有很深的积累，但以前都是帮助大药企筛选有潜力的双抗，去年公司逆向合并上市公司，实现上市，开始开发自己的双抗。公司的财务状况比较糟糕，增发随时都可能发生。请看我们的研究分析：...查看全文

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-169160  Act: 34  Size: 38 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-159605  Act: 34  Size: 429 KB 网页链接

财报披露「修正」

$Affimed(AFMD)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-156194  Act: 34  Size: 77 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-152290  Act: 34  Size: 41 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-147572  Act: 34  Size: 179 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-146116  Act: 34  Size: 37 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-080581  Act: 34  Size: 168 KB 网页链接

年度财报

$Affimed(AFMD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-24-040310  Act: 34  Size: 12 MB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-064790  Act: 34  Size: 11 KB 网页链接

财报披露

$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-059965  Act: 34  Size: 29 KB 网页链接